Haikady N. Nagaraja
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Haikady N. Nagaraja has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Yanxing Zhao
Novartis Pharmaceuticals
2 shared publications - Amy Headings
Ohio State University, Department of Human Nutrition, Columbus, USA
1 shared publication - Brad H. Rovin
Department of Medicine and the Dorothy M. Davis Heart and Lung Research Institute, Ohio State University College of Medicine and Public Health, Columbus, Ohio 43210, USA
1 shared publication - Carla K. Miller
Indiana University–Bloomington, School of Public Health 1 , Bloomington, IN
1 shared publication - Chack Yung Yu
The Ohio State University
1 shared publication - Daniel J. Birmingham
Department of Internal Medicine, Davis Heart and Lung Research Institute, Ohio State University Medical Center, Columbus, Ohio, USA
1 shared publication
Latest Publications
- 17 January 2012
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 22 (2) , 237-259
Power Analyses for Negative Binomial Models with Application to Multiple Sclerosis Clinical Trials
We use negative binomial (NB) models for the magnetic resonance imaging (MRI)-based brain lesion count data from parallel group (PG) and baseline versus treatment (BVT) trials for relapsing remitting multiple sclerosis (RRMS) patients, and describe the associated likelihood ratio (LR), score, and Wald tests. We perform power analyses and sample size estimation using the simulated percentiles of the exact distribution of the test statistics for the PG and BVT trials. When compared to the corresponding nonparametric test, the LR test results in 30–45% reduction in sample sizes for the PG trials and 25–60% reduction for the BVT trials.
- 17 January 2012
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 22 (2) , 237-259
Power Analyses for Negative Binomial Models with Application to Multiple Sclerosis Clinical Trials
We use negative binomial (NB) models for the magnetic resonance imaging (MRI)-based brain lesion count data from parallel group (PG) and baseline versus treatment (BVT) trials for relapsing remitting multiple sclerosis (RRMS) patients, and describe the associated likelihood ratio (LR), score, and Wald tests. We perform power analyses and sample size estimation using the simulated percentiles of the exact distribution of the test statistics for the PG and BVT trials. When compared to the corresponding nonparametric test, the LR test results in 30–45% reduction in sample sizes for the PG trials and 25–60% reduction for the BVT trials.
- 15 April 2011
- Published by Elsevier in Patient Education and Counseling
- Vol. 86 (1) , 84-90
Goal difficulty and goal commitment affect adoption of a lower glycemic index diet in adults with type 2 diabetes
- 15 April 2011
- Published by Elsevier in Patient Education and Counseling
- Vol. 86 (1) , 84-90
Goal difficulty and goal commitment affect adoption of a lower glycemic index diet in adults with type 2 diabetes
- 23 July 2009
- Published by Springer Nature in Annals of the Institute of Statistical Mathematics
- Vol. 63 (4) , 791-825
Fisher information in window censored renewal process data and its applications
- 23 July 2009
- Published by Springer Nature in Annals of the Institute of Statistical Mathematics
- Vol. 63 (4) , 791-825
Fisher information in window censored renewal process data and its applications
- 28 June 2007
- Published by Springer Nature in TEST
- Vol. 16 (2) , 260-261
Comments on: Progressive censoring methodology: an appraisal
- 28 June 2007
- Published by Springer Nature in TEST
- Vol. 16 (2) , 260-261
Comments on: Progressive censoring methodology: an appraisal
- 13 June 2007
- Published by Springer Nature in Metrika
- Vol. 67 (3) , 327-347
Fisher information in order statistics and their concomitants in bivariate censored samples
- 13 June 2007
- Published by Springer Nature in Metrika
- Vol. 67 (3) , 327-347
Fisher information in order statistics and their concomitants in bivariate censored samples
- Open Access
- 28 September 2006
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (10) , 3291-3299
Fluctuation in self‐perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A –1019 G allele
Objective Stress is believed to be a risk factor for systemic lupus erythematosus (SLE) flare. Two serotonin-related gene polymorphisms, the serotonin receptor 1A (5-HT1A) polymorphism at –1019C>G and the serotonin transporter LS polymorphism, have been reported to affect stress-related behaviors. The purpose of this study was to assess the relationship between self-perceived stress (SPS), variability in SPS, and the 2 serotonin-related gene polymorphisms as risk factors for SLE flare. Methods Seventy-seven SLE patients (50 with lupus nephritis) were evaluated every 2 months (mean ± SD total followup 18.5 ± 8.5 months), and patients recorded their daily SPS levels (0–10 scale). Values for mean SPS and coefficient of variation (CV) for SPS were calculated from the 60-day block of daily measurements between study visits. Serotonin-related gene polymorphism genotypes were determined by polymerase chain reaction–based methods. Results Of the 77 patients, 53 experienced 80 flares of SLE (32 renal flares) based on prespecified criteria. Multivariate analysis revealed that whereas neither the serotonin-related gene polymorphisms nor the mean SPS was predictive of an SLE flare, an increased CV for SPS was predictive (P = 0.0031). Interaction between the CV for SPS and the 5-HT1A –1019C>G polymorphism was also found to be a predictor of SLE flare (P = 0.0039). Subset analysis revealed that only in lupus nephritis patients were increasing CVs for SPS (P = 0.0002) and the interaction between CVs for SPS and 5-HT1A (P < 0.0001) predictive of a flare. Odds ratio curves demonstrated that the predictive effect of increasing CVs for SPS required the presence of the 5-HT1A –1019 G allele, but appeared to be independent of the G allele number. Conclusion Fluctuation in the level of SPS is a risk factor for the onset of flare in SLE patients with major renal manifestations when it occurs on the background of a stress-related susceptibility gene (the 5-HT1A –1019 G allele).
- 28 September 2006
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (10) , 3291-3299
Open AccessFluctuation in self‐perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A –1019 G allele
Objective Stress is believed to be a risk factor for systemic lupus erythematosus (SLE) flare. Two serotonin-related gene polymorphisms, the serotonin receptor 1A (5-HT1A) polymorphism at –1019C>G and the serotonin transporter LS polymorphism, have been reported to affect stress-related behaviors. The purpose of this study was to assess the relationship between self-perceived stress (SPS), variability in SPS, and the 2 serotonin-related gene polymorphisms as risk factors for SLE flare. Methods Seventy-seven SLE patients (50 with lupus nephritis) were evaluated every 2 months (mean ± SD total followup 18.5 ± 8.5 months), and patients recorded their daily SPS levels (0–10 scale). Values for mean SPS and coefficient of variation (CV) for SPS were calculated from the 60-day block of daily measurements between study visits. Serotonin-related gene polymorphism genotypes were determined by polymerase chain reaction–based methods. Results Of the 77 patients, 53 experienced 80 flares of SLE (32 renal flares) based on prespecified criteria. Multivariate analysis revealed that whereas neither the serotonin-related gene polymorphisms nor the mean SPS was predictive of an SLE flare, an increased CV for SPS was predictive (P = 0.0031). Interaction between the CV for SPS and the 5-HT1A –1019C>G polymorphism was also found to be a predictor of SLE flare (P = 0.0039). Subset analysis revealed that only in lupus nephritis patients were increasing CVs for SPS (P = 0.0002) and the interaction between CVs for SPS and 5-HT1A (P < 0.0001) predictive of a flare. Odds ratio curves demonstrated that the predictive effect of increasing CVs for SPS required the presence of the 5-HT1A –1019 G allele, but appeared to be independent of the G allele number. Conclusion Fluctuation in the level of SPS is a risk factor for the onset of flare in SLE patients with major renal manifestations when it occurs on the background of a stress-related susceptibility gene (the 5-HT1A –1019 G allele).